More Sudarshan Pharma Industries Ltd news
Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Reg. 34 (1) Annual Report.

Jul 1, 2025 at 5:58 AM EDT · Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · Jul 1, 2025 at 5:58 AM EDT

On 6ix: 6ix.com/news/reg-34-1-annual-report-635

Annual Report of the Company for the financial year 2024-25 is attached herewith.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

  • Sudarshan Pharma Industries Ltd Press Release Jun 30 2025Jun 30, 2025
  • Closure of Trading WindowJun 30, 2025
  • Sudarshan Pharma Industries Ltd Press Release Jun 19 2025Jun 19, 2025
  • Announcement under Regulation 30 (LODR)-AcquisitionJun 19, 2025
  • Announcement under Regulation 30 (LODR)-Issue of SecuritiesJun 19, 2025

Later from Sudarshan Pharma Industries

  • Annual General Meeting On Friday, 25Th July 2025 At 3.00 P.M. ISTJul 1, 2025
  • Sudarshan Pharma Industries Ltd Press Release Jul 01 2025Jul 1, 2025
  • Notice Of Extraordinary General Meeting Of The CompanyJul 17, 2025
  • Sudarshan Pharma Industries Ltd Press Release Jul 17 2025Jul 17, 2025
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 21, 2025
All Sudarshan Pharma Industries news releases↗

Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.

Follow Sudarshan Pharma Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer